Climedo Health
Generated 5/9/2026
Executive Summary
Climedo Health is a Germany-based digital health company founded in 2017, offering an integrated platform for electronic data capture (EDC), electronic clinical outcome assessment (eCOA/ePRO), electronic case report forms (eCRF), and electronic consent (eConsent). Its solutions are specifically designed for non-interventional studies and real-world evidence (RWE) generation, enabling life science companies to streamline data collection, enhance communication with healthcare professionals (HCPs), and gain real-time insights into study progress. By focusing on the growing RWE market, Climedo addresses the need for efficient, patient-centric data gathering in post-market and observational research. The company is headquartered in Munich, Germany, and operates in a competitive landscape alongside larger players like Medidata and Veeva, but differentiates itself through a modular, flexible platform tailored to mid-sized biopharma firms and contract research organizations (CROs).
Upcoming Catalysts (preview)
- Q3 2026Strategic partnership with a top-20 pharma company for RWE trials60% success
- Q4 2026Launch of AI-driven predictive analytics module for patient engagement50% success
- Q3 2026Expansion into the U.S. market via FDA-compliant SaaS offering45% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)